Corvex Deferred Tax Assets Capitalized Research And Development decreased by 27.5% to $5.16M in Q4 2025 compared to the prior quarter. Over 2 years (FY 2023 to FY 2025), Deferred Tax Assets Capitalized Research And Development shows a downward trend with a -7.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates higher tax-deductible R&D spending that will lower future tax payments.
This represents the tax benefit arising from the capitalization of research and development expenses for tax purposes, w...
Standard for technology companies subject to tax laws requiring R&D capitalization; peers report this in deferred tax disclosures.
other_deferred_tax_assets_capitalized_research_and_devel_3897a0| Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|
| Value | $5.96M | $7.12M | $5.16M |
| QoQ Change | — | +19.3% | -27.5% |
| YoY Change | — | +19.3% | -27.5% |